Processa Pharmaceuticals, Inc. · NASDAQ:PCSA
Young David bought 1,706 Processa Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 30, 2026 · Filed May 1, 2026
On Apr 30, 2026, Young David (Director, Pres. Research & Development) bought 1,706 Processa Pharmaceuticals, Inc. shares at US$2.69 for US$4,589, leaving 13,813 shares. Filed May 1, 2026 (Form 4).
- Bought
- 1,706 shares
- Price
- US$2.69
- Value
- US$4,589
- Holding after
- 13,813 shares
- Trading plan
- No
- Role
- Director, Pres. Research & Development
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Common Stock | Buy | 1,706 | US$2.69 | 13,813 | Direct |
Source
Related
- Processa Pharmaceuticals, Inc.
- Young David
- Processa Pharmaceuticals, Inc. shareholders
- Form 4 · Young David · Jul 1, 2026
- Form 4 · Young David · Jun 16, 2026
- Form 4 · Young David · Jun 1, 2026
- Form 4 · Young David · May 19, 2026
- Form 4 · Young David · Apr 17, 2026
- Schedule 13G · Soleus Capital Master Fund, L.P. · Aug 18, 2026
- Form 4 · Ng George K · Aug 11, 2026
- Form 4 · Ng George K · Jul 1, 2026
- Form 4 · Guy Wendy · Jul 1, 2026
- Form 4 · Lin Patrick · Jul 1, 2026